Can biomarkers guide treatment or track response in endometriosis?

Biomarkers are promising, but they’re not yet a reliable way to choose a specific endometriosis treatment or to measure, in real time, how well a therapy is working. In research settings, multi-marker panels may eventually help stratify inflammation or disease activity and support more individualized decisions about hormonal suppression, pain management strategies, or the timing of excision.

Right now, the most dependable way we monitor response is still how you feel and function over time, paired with clinical evaluation and imaging when appropriate. In select situations—such as monitoring a large endometrioma—your team may follow a lab like CA-125 as one piece of the picture, but it’s not specific enough to use alone. If you’re interested in whether biomarker testing could add value in your case, our team can walk you through what’s available, what it can and can’t tell us, and how we’d use it alongside symptoms and imaging.